UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acquired coagulopathy in patients with left ventricular assist devices

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.429-440

2018

Volltextzugriff (PDF)

Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and management

Hematology, 2019-12, Vol.2019 (1), p.88-96

2019

Volltextzugriff (PDF)

A diagnostic approach to mild bleeding disorders

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1507-1516

2016

Volltextzugriff (PDF)

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII

Journal of thrombosis and haemostasis, 2016-07, Vol.14 (7), p.1453-1461

2016

Volltextzugriff (PDF)

Anticoagulant therapy in patients with non‐cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding

Journal of thrombosis and haemostasis, 2013-03, Vol.11 (3), p.452-459

2013

Volltextzugriff (PDF)

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Clinical endocrinology (Oxford), 2013-04, Vol.78 (4), p.481-488

2013

Volltextzugriff (PDF)

Von Willebrand disease: Clinical conundrums

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (S6), p.37-43

2018

Volltextzugriff (PDF)

Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII

Thrombosis and haemostasis, 2018-03, Vol.118 (3), p.514-525

2018

Volltextzugriff (PDF)

Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?

Blood reviews, 2018-07, Vol.32 (4), p.265-271

2018

Volltextzugriff (PDF)

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients

European journal of clinical pharmacology, 2022-02, Vol.78 (2), p.237-249

2022

Volltextzugriff (PDF)

Plasma ADAMTS‐13 levels and the risk of myocardial infarction: an individual patient data meta‐analysis

Journal of thrombosis and haemostasis, 2015-08, Vol.13 (8), p.1396-1404

2015

Volltextzugriff (PDF)

Coagulation disorders after traumatic brain injury

Acta neurochirurgica, 2008-02, Vol.150 (2), p.165-175

2008

Volltextzugriff (PDF)

Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests

Journal of thrombosis and haemostasis, 2012-10, Vol.10 (10), p.2116-2122

2012

Volltextzugriff (PDF)

von Willebrand disease and aging: an evolving phenotype

Journal of thrombosis and haemostasis, 2014-07, Vol.12 (7), p.1066-1075

2014

Volltextzugriff (PDF)

Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications

Journal of thrombosis and haemostasis, 2016-03, Vol.14 (3), p.468-478

2016

Volltextzugriff (PDF)

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients

Atherosclerosis, 2009-11, Vol.207 (1), p.250-254

2009

Volltextzugriff (PDF)

Clinically relevant differences between assays for von Willebrand factor activity

Journal of thrombosis and haemostasis, 2018-12, Vol.16 (12), p.2413-2424

2018

Volltextzugriff (PDF)

Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network

Journal of thrombosis and haemostasis, 2015-09, Vol.13 (9), p.1585-1589

2015

Volltextzugriff (PDF)

Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms

Journal of thrombosis and haemostasis, 2011-11, Vol.9 (11), p.2208-2214

2011

Volltextzugriff (PDF)

Intensity of factor VIII treatment and the development of inhibitors in non‐severe hemophilia A patients: results of the INSIGHT case–control study

Journal of thrombosis and haemostasis, 2017-07, Vol.15 (7), p.1422-1429

2017

Volltextzugriff (PDF)

Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.505-512

2015

Volltextzugriff (PDF)

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1303-1310

2012

Volltextzugriff (PDF)

Low ADAMTS‐13 activity and the risk of coronary heart disease – a prospective cohort study: the Rotterdam Study

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2114-2120

2016

Volltextzugriff (PDF)

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review

Journal of thrombosis and haemostasis, 2011-05, Vol.9 (5), p.899-908

2011

Volltextzugriff (PDF)

CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.956-966

2015

Volltextzugriff (PDF)

1 – 25 von 267

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(228)

Publikationsform

Artikel
(265)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(204)
Life Sciences & Biomedicine
(200)
Humans
(192)
Hematology
(150)
Male
(115)
Female
(112)
Middle Aged
(105)
Cardiovascular System & Cardiology
(100)
Peripheral Vascular Disease
(97)
Adult
(90)
Aged
(74)
Biological And Medical Sciences
(54)
Medical Sciences
(51)
Adolescent
(48)
Risk Factors
(43)
Young Adult
(38)
Von Willebrand Factor
(32)
Hemophilia
(31)
Child
(28)
Bleeding
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acquired coagulopathy in patients with left ventricular assist devices

Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and management

A diagnostic approach to mild bleeding disorders

Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII

Anticoagulant therapy in patients with non‐cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Von Willebrand disease: Clinical conundrums

Cross-evaluation of Pharmacokinetic-Guided Dosing Tools for Factor VIII

Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients

Plasma ADAMTS‐13 levels and the risk of myocardial infarction: an individual patient data meta‐analysis

Coagulation disorders after traumatic brain injury

Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests

von Willebrand disease and aging: an evolving phenotype

Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients

Clinically relevant differences between assays for von Willebrand factor activity

Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network

Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms

Intensity of factor VIII treatment and the development of inhibitors in non‐severe hemophilia A patients: results of the INSIGHT case–control study

Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

Low ADAMTS‐13 activity and the risk of coronary heart disease – a prospective cohort study: the Rotterdam Study

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review

CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease

Suchergebnisse filtern